Stericycle (NASDAQ:SRCL) Rating Reaffirmed
The financial company has just set a target price per share of $119.0 on Stericycle (NASDAQ:SRCL) shares. This is -1.40% from the close price. In an analyst note released on Monday, 30 November, RBC Capital Mkts has restated their Sector Perform rating on shares of SRCL.
From a total of 8 analysts covering Stericycle (NASDAQ:SRCL) stock, 3 rate it a ”Buy”, 0 a “Sell”, and 5 a ”Hold”. This means that 38% of the ratings are positive. The highest target price is $160 while the lowest target price is $122. The mean of all analyst targets is $137 with a 13.51% above today’s ($120.69) stock price. Stericycle was the topic of 11 analyst reports since August 14, 2015 according to the firm StockzIntelligence Inc. Imperial Capital maintained shares on October 26 with “In-Line” rating. Robert W. Baird downgraded shares to “Neutral” rating and $130 target share price in a report from an October 23. Oppenheimer downgraded SRCL stock in a recent report from October 23 to “Perform” rating. Finally, RBC Capital Markets maintained the stock with “Sector Perform” rating in a report issued on an October 23.
The stock decreased 1.41% or $1.72 on November 27, striking $120.69. Approximately shares of stock traded hands. Stericycle Inc (NASDAQ:SRCL) has declined 10.64% since April 27, 2015 and is downtrending. It has underperformed by 9.75% the S&P500.
Stericycle, Inc. is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The company has a market cap of $10.26 billion. The Company’s solutions include the collection and processing of specialized waste for disposal, and a variety of training, consulting, recall/return, communication, and compliance services, which include training, consulting, inbound/outbound communications, data reporting, and other regulatory compliance services. It has 38.69 P/E ratio. The Firm operates regulated waste management networks in the United States, Argentina, Brazil, Canada, Chile, Ireland, Japan, Mexico, Portugal, Romania, South Korea, Spain, and the United Kingdom.
According to Zacks Investment Research, “Stericycle, Inc. is a multi-regional integrated company employing proprietary technology to provide environmentally-responsible management of regulated medical waste for the health care industry. The Company is the second-largest provider of regulated medical waste management services in the United States.” Get a free copy of the Zacks research report on Stericycle Inc (SRCL)